KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Accumulated Depreciation & Amortization (2016 - 2025)

Boston Scientific's Accumulated Depreciation & Amortization history spans 17 years, with the latest figure at $1.4 billion for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 7.8% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 7.8%, while the annual FY2025 figure was $1.4 billion, 7.8% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $1.4 billion at Boston Scientific, up from $1.0 billion in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.4 billion in Q4 2025 and bottomed at $268.0 million in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $732.0 million (2021), against an average of $745.9 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization dropped 3.8% in 2021 before it grew 8.9% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $1.1 billion in 2021, then grew by 3.93% to $1.1 billion in 2022, then grew by 5.28% to $1.2 billion in 2023, then grew by 6.1% to $1.3 billion in 2024, then increased by 7.8% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Accumulated Depreciation & Amortization are $1.4 billion (Q4 2025), $1.0 billion (Q3 2025), and $661.0 million (Q2 2025).